1 |
K. Lachenmeier, F. Musshoff, and B. Madea, Forensic Sci. Int., 159, 189-199 (2006).
DOI
|
2 |
M. A. von Mach, C. Weber, M. R. Meyer, L. S. Weilemann, H. H. Maurer, and F. T. Peters, Ther. Drug Monit., 29, 27-39 (2007).
DOI
|
3 |
L. Broussard, Chap. 20 Interpretation of amphetamines screening and confirmation testing, in: A. Dasgupta (Ed), Handbook of Drug Monitoring Methods - Therapeutics and Drugs of Abuse, p379, Humana Press, New Jersey, 2008.
|
4 |
M. Cheze, M. Deveaux, C. Martin, M. Lhermitte, and G. Pepin, Forensic Sci. Int., 170, 100-104 (2007).
DOI
|
5 |
A. D. De Jager and N. L. Bailey, J. Chromatogr. B, 879, 2642-2652 (2011).
DOI
|
6 |
I. L. Tsai, T. I. Weng, Y. J. Tseng, H. K. L. Tan, H. J. Sun, and C. H. Kuo, J. Anal. Toxicol. 37, 642-651 (2013).
DOI
|
7 |
X. Li, B. Shen, Z. Jiang, Y. Huang, and X. Zhuo, J. Chromatogr. A, 1302, 95-104 (2013).
DOI
|
8 |
K. Hara, S. Kashimura, Y. Hieda, and M. Kageura, J. Anal. Toxicol., 21, 54-58 (1997).
DOI
|
9 |
Y. Iwasaki, T. Sawada, K. Hatayama, A. Ohyagi, Y. Tsukuda, K. Namekawa, R. Ito, K. Saito, and H. Nakazawa, Metabolites, 2, 496-515 (2012).
DOI
|
10 |
F. T. Peters, O. H. Drummer, and F. Musshoff, Forensic Sci. Int., 165, 216-224 (2007).
DOI
|
11 |
U.S. Department of Health Human Services, Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation in U.S., Beltsville, MD, 2001.
|
12 |
B. K. Matuszewski, M. L. Constanzer, and C. M. Chavez-Eng, Anal. Chem., 75, 3019-3030 (2003).
DOI
|
13 |
R. A. Glennon, Pharmacol. Biochem. Behav., 64, 251-256 (1999).
DOI
|
14 |
United Nations Office on Drugs and Crime, World Drug Report 2017, Vienna, United Nations, 2017.
|
15 |
Supreme Prosecutors' Office, White Paper on Drug-Related Crimes 2016, Seoul, Korea, 2017.
|
16 |
J. Caldwell, L. G. Dring, and R. T. Williams, Biochem. J., 129, 11-22 (1972).
DOI
|
17 |
T. R. Gray, T. Kelly, L. L. LaGasse, L. M. Smith, C. Derauf, W. Haning, P. Grant, R. Shah, A. Arria, A. Strauss, B. M. Lester, and M. A. Huestis, Ther. Drug Monit., 31, 70-75 (2008).
|
18 |
W. A. Wan Raihana, S. H. Gan, and S. C. Tan, J. Chromatogr. B, 879, 8-16 (2011).
DOI
|
19 |
L. G. Dring, R. L. Smith, and R. T. Williams, Biochem. J. 116, 425-435 (1970).
DOI
|
20 |
A. K. Cho and J. Wright, Life Sci., 22, 363-372 (1978).
DOI
|
21 |
R. D. Stevenson and M. L. Wolraich, Pediatr. Clin. North Am., 36, 1183-1197 (1989).
DOI
|
22 |
J. D. Parkes and G. W. Fenton, J. Neurol. Neurosurg. Psychiatry, 36, 1076-1081 (1973).
DOI
|
23 |
K. Orr and D. Taylor, CNS Drugs, 21, 239-257 (2007).
DOI
|
24 |
C. M. Hartung, W. H. Canu, C. S. Cleveland, E. K. Lefler, M. J. Mignogna, D. A. Fedele, C. J. Correia, T. R. Leffingwell, and J. D. Clapp, Psychol. Addict. Behav,. 27, 832-840 (2013).
DOI
|
25 |
J. Mazanov, M. Dunn, J. Connor, and M.-L. Fielding, Performance Enhancement & Health, 2, 110-118 (2013).
DOI
|
26 |
A. D. DeSantis, E. M. Webb, and S. M. Noar, J. Am. Coll. Health, 57, 315-324 (2008).
DOI
|
27 |
M. R. Meyer and H. H. Maurer, Pharmacogenomics, 12, 215-233 (2011).
DOI
|
28 |
W. Kwon, S. I. Suh, M. K. In, and J. Y. Kim, Mass Spectrom. Lett., 5, 104-109 (2014).
DOI
|